BridgeBio Pharma (BBIO) Stock: Buy, Sell, or Hold?
BBIO - BridgeBio Pharma, Inc. Common Stock
$74.03
-0.97 (-1.29%)
▼
5d:
+6.72%
30d:
+11.93%
90d:
-9.71%
WAIT
LOW Confidence
Analysis Updated: Nov 3, 2026 12:00 AM ET
Earnings: Oct 29, 2026
0d
Smart Money Distribution
Options positioning is turning defensive after a sharp run-up - a pattern consistent with institutional profit-taking. View Scanner →
Signal fired Oct 30, 2026 at $74.95 · last confirmed Nov 3, 2026
Strength: 8.0/10
Get Alerted When BBIO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: BBIO shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: BBIO shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: BBIO is currently trading at $74.03, which is considered extended relative to its 30-day fair value range of $64.93 to $70.68. From a valuation perspective, the stock is trading at a discount (Forward PE: -228.5) compared to its historical average (207.4). At these levels, the market is pricing in 0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, BBIO is in a strong uptrend. Immediate support is located at $67.02, while resistance sits at $76.79.
Market Sentiment: BBIO scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $106.85 (+44.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, BBIO is in a strong uptrend. Immediate support is located at $67.02, while resistance sits at $76.79.
Market Sentiment: BBIO scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $106.85 (+44.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$64.93 -
$70.68
Company Quality Score
41/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
33.3%
Protect Your Profits
Holding BBIO? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range
- BEARISH: Weak technical setup (15/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 44.3% below Wall St target ($106.85)
- BULLISH: Market expects only 0% annual growth - appears undervalued
- WARNING: Composite score 41/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$64.93 -
$70.68
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$67.02
Resistance Level
$76.79
Current Trend
Strong Uptrend
Technical data as of
Nov 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-228.49
Wall Street Target
$106.85
(+44.3%)
Revenue Growth (YoY)
192.6%
Profit Margin
-59.8%
PE vs Historical
-228.5 vs 207.4
CHEAP
Share & Embed Analysis
Last updated: November 04, 2026 8:20 AM ET
Data refreshes hourly during market hours. Next update: 9:20 AM
Data refreshes hourly during market hours. Next update: 9:20 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BBIO showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ARGX
argenx NV ADR |
STRONG BUY
23 analysts |
$1147 | 53 HOLD |
|
IRD
Opus Genetics, Inc. |
STRONG BUY
18 analysts |
$13 | 62 BUY |
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
24 analysts |
$144 | 35 SELL |
|
BNTX
BioNTech SE |
BUY
21 analysts |
$117 | 63 BUY |
|
DNTH
Dianthus Therapeutics In… |
STRONG BUY
18 analysts |
$139 | 44 HOLD |
Advanced BBIO Option Strategies
Professional options setups generated by AI based on today's BBIO price and gamma walls.
